CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Coya Therapeutics Says Phase 2 ALS Study Enters Blinded Extension Phase

Phase 2Neutral
AI Analysis

Summary

Coya Therapeutics announced that its Phase 2 ALS study has advanced to the blinded extension phase.

Clinical Trial Data

Phase

2

Outcome Details

Phase 2 ALS study enters blinded extension phase

Importance:5/10
Sentiment:
0.20
Phase 2ALSclinical trialextension phase
Related Companies

Read the original article

Published by yahoo_finance on June 8, 2026 1:22 PM

Read Original